biogen waen limited
biogen waen limited Company Information
Company Number
07816570
Next Accounts
Dec 2025
Shareholders
biogen (uk) limited
iona environmental infrastructure holdco limited
Group Structure
View All
Industry
Production of electricity
+1Registered Address
milton parc milton ernest, bedfordshire, MK44 1YU
Website
www.biogen.co.ukbiogen waen limited Estimated Valuation
Pomanda estimates the enterprise value of BIOGEN WAEN LIMITED at £3m based on a Turnover of £3.1m and 0.96x industry multiple (adjusted for size and gross margin).
biogen waen limited Estimated Valuation
Pomanda estimates the enterprise value of BIOGEN WAEN LIMITED at £4.6m based on an EBITDA of £1.3m and a 3.6x industry multiple (adjusted for size and gross margin).
biogen waen limited Estimated Valuation
Pomanda estimates the enterprise value of BIOGEN WAEN LIMITED at £4.7m based on Net Assets of £1.8m and 2.59x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biogen Waen Limited Overview
Biogen Waen Limited is a live company located in bedfordshire, MK44 1YU with a Companies House number of 07816570. It operates in the production of electricity sector, SIC Code 35110. Founded in October 2011, it's largest shareholder is biogen (uk) limited with a 55% stake. Biogen Waen Limited is a established, small sized company, Pomanda has estimated its turnover at £3.1m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Biogen Waen Limited Health Check
Pomanda's financial health check has awarded Biogen Waen Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 3 areas for improvement. Company Health Check FAQs
2 Strong
4 Regular
3 Weak
Size
annual sales of £3.1m, make it smaller than the average company (£8.5m)
£3.1m - Biogen Waen Limited
£8.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 14%, show it is growing at a faster rate (10%)
14% - Biogen Waen Limited
10% - Industry AVG
Production
with a gross margin of 28.4%, this company has a higher cost of product (46.5%)
28.4% - Biogen Waen Limited
46.5% - Industry AVG
Profitability
an operating margin of 23.5% make it as profitable than the average company (29%)
23.5% - Biogen Waen Limited
29% - Industry AVG
Employees
with 10 employees, this is below the industry average (22)
- Biogen Waen Limited
22 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Biogen Waen Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £312.7k, this is equally as efficient (£347.9k)
- Biogen Waen Limited
£347.9k - Industry AVG
Debtor Days
it gets paid by customers after 20 days, this is near the average (24 days)
20 days - Biogen Waen Limited
24 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Biogen Waen Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Biogen Waen Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 14 weeks, this is average cash available to meet short term requirements (14 weeks)
14 weeks - Biogen Waen Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 39.3%, this is a lower level of debt than the average (78.1%)
39.3% - Biogen Waen Limited
78.1% - Industry AVG
BIOGEN WAEN LIMITED financials
Biogen Waen Limited's latest turnover from March 2024 is £3.1 million and the company has net assets of £1.8 million. According to their latest financial statements, we estimate that Biogen Waen Limited has 10 employees and maintains cash reserves of £155 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3,127,000 | 2,781,000 | 2,007,000 | 2,118,000 | 2,337,000 | 2,219,000 | 2,812,000 | 2,046,000 | 2,239,000 | 886,000 | ||
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | 2,239,000 | 1,865,000 | 1,603,000 | 1,674,000 | 1,593,000 | 1,498,000 | 1,822,000 | 1,356,000 | 1,471,000 | 706,000 | ||
| Gross Profit | 888,000 | 916,000 | 404,000 | 444,000 | 744,000 | 721,000 | 990,000 | 690,000 | 768,000 | 180,000 | ||
| Admin Expenses | 154,000 | 141,000 | 132,000 | 132,000 | 130,000 | 77,000 | 163,000 | 118,000 | 118,000 | 95,000 | 91,000 | |
| Operating Profit | 734,000 | 775,000 | 272,000 | 312,000 | 614,000 | 644,000 | 827,000 | 572,000 | 650,000 | 85,000 | -91,000 | -9,000 |
| Interest Payable | 39,000 | 166,000 | 261,000 | 327,000 | 403,000 | 495,000 | 697,000 | 614,000 | 648,000 | 287,000 | ||
| Interest Receivable | ||||||||||||
| Pre-Tax Profit | 695,000 | 609,000 | 11,000 | -15,000 | 211,000 | 149,000 | 130,000 | -42,000 | 2,000 | -202,000 | -91,000 | -9,000 |
| Tax | 42,000 | -158,000 | -66,000 | -50,000 | -65,000 | -39,000 | -8,000 | 32,000 | ||||
| Profit After Tax | 737,000 | 451,000 | -55,000 | -15,000 | 161,000 | 84,000 | 91,000 | -50,000 | 34,000 | -202,000 | -91,000 | -9,000 |
| Dividends Paid | 418,000 | |||||||||||
| Retained Profit | 319,000 | 451,000 | -55,000 | -15,000 | 161,000 | 84,000 | 91,000 | -50,000 | 34,000 | -202,000 | -91,000 | -9,000 |
| Employee Costs | ||||||||||||
| Number Of Employees | ||||||||||||
| EBITDA* | 1,281,000 | 1,333,000 | 850,000 | 890,000 | 1,214,000 | 1,272,000 | 1,595,000 | 1,172,000 | 1,252,000 | 335,000 | -91,000 | -9,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,375,000 | 2,842,000 | 3,395,000 | 3,973,000 | 4,525,000 | 5,119,000 | 5,675,000 | 6,293,000 | 6,866,000 | 7,468,000 | 5,052,000 | 705,000 |
| Intangible Assets | ||||||||||||
| Investments & Other | ||||||||||||
| Debtors (Due After 1 year) | 890,000 | |||||||||||
| Total Fixed Assets | 2,375,000 | 2,842,000 | 3,395,000 | 3,973,000 | 4,525,000 | 5,119,000 | 5,675,000 | 6,293,000 | 6,866,000 | 7,468,000 | 5,052,000 | 1,595,000 |
| Stock & work in progress | ||||||||||||
| Trade Debtors | 177,000 | 145,000 | 146,000 | 148,000 | 302,000 | 208,000 | 185,000 | 198,000 | 182,000 | 238,000 | 114,000 | 116,000 |
| Group Debtors | 1,000 | 21,000 | 57,000 | 15,000 | 15,000 | |||||||
| Misc Debtors | 255,000 | 241,000 | 224,000 | 226,000 | 332,000 | 456,000 | 377,000 | 268,000 | 257,000 | 310,000 | 1,494,000 | 121,000 |
| Cash | 155,000 | 118,000 | 86,000 | 86,000 | 38,000 | 28,000 | 25,000 | 40,000 | 8,000 | 62,000 | 1,195,000 | 376,000 |
| misc current assets | ||||||||||||
| total current assets | 587,000 | 504,000 | 456,000 | 460,000 | 673,000 | 713,000 | 644,000 | 506,000 | 462,000 | 625,000 | 2,803,000 | 613,000 |
| total assets | 2,962,000 | 3,346,000 | 3,851,000 | 4,433,000 | 5,198,000 | 5,832,000 | 6,319,000 | 6,799,000 | 7,328,000 | 8,093,000 | 7,855,000 | 2,208,000 |
| Bank overdraft | ||||||||||||
| Bank loan | ||||||||||||
| Trade Creditors | 37,000 | 38,000 | 35,000 | 37,000 | 36,000 | 7,000 | 17,000 | 24,000 | 40,000 | 4,000 | ||
| Group/Directors Accounts | 139,000 | 166,000 | 188,000 | 149,000 | 126,000 | 179,000 | 73,000 | 162,000 | 129,000 | 96,000 | 989,000 | 500,000 |
| other short term finances | ||||||||||||
| hp & lease commitments | ||||||||||||
| other current liabilities | 418,000 | 252,000 | 112,000 | 154,000 | 153,000 | 118,000 | 137,000 | 91,000 | 143,000 | 580,000 | 45,000 | 60,000 |
| total current liabilities | 557,000 | 455,000 | 338,000 | 338,000 | 316,000 | 333,000 | 217,000 | 270,000 | 296,000 | 716,000 | 1,038,000 | 560,000 |
| loans | 670,000 | 1,800,000 | 2,305,000 | 2,985,000 | 3,770,000 | 4,385,000 | 4,860,000 | 5,280,000 | 5,580,000 | 5,634,000 | 542,000 | |
| hp & lease commitments | ||||||||||||
| Accruals and Deferred Income | 284,000 | 365,000 | 444,000 | 523,000 | 602,000 | 682,000 | 762,000 | 860,000 | 940,000 | 1,019,000 | ||
| other liabilities | 203,000 | 35,000 | ||||||||||
| provisions | 323,000 | 377,000 | 241,000 | 184,000 | 197,000 | 110,000 | 102,000 | 47,000 | ||||
| total long term liabilities | 607,000 | 1,412,000 | 2,485,000 | 3,012,000 | 3,784,000 | 4,562,000 | 5,249,000 | 5,767,000 | 6,220,000 | 6,599,000 | 5,837,000 | 577,000 |
| total liabilities | 1,164,000 | 1,867,000 | 2,823,000 | 3,350,000 | 4,100,000 | 4,895,000 | 5,466,000 | 6,037,000 | 6,516,000 | 7,315,000 | 6,875,000 | 1,137,000 |
| net assets | 1,798,000 | 1,479,000 | 1,028,000 | 1,083,000 | 1,098,000 | 937,000 | 853,000 | 762,000 | 812,000 | 778,000 | 980,000 | 1,071,000 |
| total shareholders funds | 1,798,000 | 1,479,000 | 1,028,000 | 1,083,000 | 1,098,000 | 937,000 | 853,000 | 762,000 | 812,000 | 778,000 | 980,000 | 1,071,000 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | 734,000 | 775,000 | 272,000 | 312,000 | 614,000 | 644,000 | 827,000 | 572,000 | 650,000 | 85,000 | -91,000 | -9,000 |
| Depreciation | 547,000 | 558,000 | 578,000 | 578,000 | 600,000 | 628,000 | 768,000 | 600,000 | 602,000 | 250,000 | ||
| Amortisation | ||||||||||||
| Tax | 42,000 | -158,000 | -66,000 | -50,000 | -65,000 | -39,000 | -8,000 | 32,000 | ||||
| Stock | ||||||||||||
| Debtors | 46,000 | 16,000 | -4,000 | -261,000 | -50,000 | 66,000 | 619,000 | 12,000 | -109,000 | -1,045,000 | 481,000 | 1,127,000 |
| Creditors | -37,000 | -1,000 | 3,000 | -2,000 | 1,000 | 29,000 | 7,000 | -7,000 | -16,000 | 36,000 | 4,000 | |
| Accruals and Deferred Income | 85,000 | 61,000 | -121,000 | -78,000 | -45,000 | -99,000 | 899,000 | -132,000 | -516,000 | 1,554,000 | -15,000 | 60,000 |
| Deferred Taxes & Provisions | -54,000 | 136,000 | 57,000 | -13,000 | 87,000 | 8,000 | 102,000 | 47,000 | ||||
| Cash flow from operations | 1,271,000 | 1,355,000 | 727,000 | 1,058,000 | 1,257,000 | 1,079,000 | 1,945,000 | 1,060,000 | 861,000 | 2,970,000 | -583,000 | -1,076,000 |
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | ||||||||||||
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | ||||||||||||
| Group/Directors Accounts | -27,000 | -22,000 | 39,000 | 23,000 | -53,000 | 106,000 | 73,000 | 33,000 | 33,000 | -893,000 | 489,000 | 500,000 |
| Other Short Term Loans | ||||||||||||
| Long term loans | -670,000 | -1,130,000 | -505,000 | -680,000 | -785,000 | -615,000 | 4,385,000 | -420,000 | -300,000 | -54,000 | 5,092,000 | 542,000 |
| Hire Purchase and Lease Commitments | ||||||||||||
| other long term liabilities | -203,000 | 168,000 | 35,000 | |||||||||
| share issue | ||||||||||||
| interest | -39,000 | -166,000 | -261,000 | -327,000 | -403,000 | -495,000 | -697,000 | -614,000 | -648,000 | -287,000 | ||
| cash flow from financing | -736,000 | -1,318,000 | -727,000 | -984,000 | -1,241,000 | -1,004,000 | 4,523,000 | -1,001,000 | -915,000 | -1,437,000 | 5,749,000 | 2,157,000 |
| cash and cash equivalents | ||||||||||||
| cash | 37,000 | 32,000 | 48,000 | 10,000 | 3,000 | 25,000 | 32,000 | -54,000 | -1,133,000 | 819,000 | 376,000 | |
| overdraft | ||||||||||||
| change in cash | 37,000 | 32,000 | 48,000 | 10,000 | 3,000 | 25,000 | 32,000 | -54,000 | -1,133,000 | 819,000 | 376,000 |
biogen waen limited Credit Report and Business Information
Biogen Waen Limited Competitor Analysis
Perform a competitor analysis for biogen waen limited by selecting its closest rivals, whether from the ELECTRICITY, GAS, STEAM AND AIR CONDITIONING SUPPLY sector, other small companies, companies in MK44 area or any other competitors across 12 key performance metrics.
biogen waen limited Ownership
BIOGEN WAEN LIMITED group structure
Biogen Waen Limited has no subsidiary companies.
Ultimate parent company
2 parents
BIOGEN WAEN LIMITED
07816570
biogen waen limited directors
Biogen Waen Limited currently has 4 directors. The longest serving directors include Mr John Kutner (Feb 2015) and Mr Graeme Vincent (Mar 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr John Kutner | 84 years | Feb 2015 | - | Director | |
| Mr Graeme Vincent | United Kingdom | 59 years | Mar 2017 | - | Director |
| Mr Adam Feneley | United Kingdom | 45 years | Feb 2024 | - | Director |
| Mr Matthew Hughes | United Kingdom | 47 years | Aug 2024 | - | Director |
P&L
March 2024turnover
3.1m
+12%
operating profit
734k
-5%
gross margin
28.4%
-13.78%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
1.8m
+0.22%
total assets
3m
-0.11%
cash
155k
+0.31%
net assets
Total assets minus all liabilities
biogen waen limited company details
company number
07816570
Type
Private limited with Share Capital
industry
35110 - Production of electricity
38210 - Treatment and disposal of non-hazardous waste
incorporation date
October 2011
age
14
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2024
previous names
biogen llwydlo limited (August 2012)
accountant
-
auditor
GRANT THORNTON UK LLP
address
milton parc milton ernest, bedfordshire, MK44 1YU
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
HCR LEGAL LLP
biogen waen limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to biogen waen limited.
biogen waen limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOGEN WAEN LIMITED. This can take several minutes, an email will notify you when this has completed.
biogen waen limited Companies House Filings - See Documents
| date | description | view/download |
|---|
